These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


299 related items for PubMed ID: 38740349

  • 21. Subthalamic deep brain stimulation at individualized frequencies for Parkinson disease.
    Tsang EW, Hamani C, Moro E, Mazzella F, Saha U, Lozano AM, Hodaie M, Chuang R, Steeves T, Lim SY, Neagu B, Chen R.
    Neurology; 2012 Jun 12; 78(24):1930-8. PubMed ID: 22592373
    [Abstract] [Full Text] [Related]

  • 22. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
    Devos D, Labyt E, Derambure P, Bourriez JL, Cassim F, Reyns N, Blond S, Guieu JD, Destée A, Defebvre L.
    Brain; 2004 Feb 12; 127(Pt 2):408-19. PubMed ID: 14691060
    [Abstract] [Full Text] [Related]

  • 23. Functional and effective connectivity in subthalamic local field potential recordings of patients with Parkinson's disease.
    Hohlefeld FU, Huchzermeyer C, Huebl J, Schneider GH, Nolte G, Brücke C, Schönecker T, Kühn AA, Curio G, Nikulin VV.
    Neuroscience; 2013 Oct 10; 250():320-32. PubMed ID: 23876322
    [Abstract] [Full Text] [Related]

  • 24. High-frequency stimulation of the subthalamic nucleus selectively decreases central variance of rhythmic finger tapping in Parkinson's disease.
    Joundi RA, Brittain JS, Green AL, Aziz TZ, Jenkinson N.
    Neuropsychologia; 2012 Aug 10; 50(10):2460-6. PubMed ID: 22749972
    [Abstract] [Full Text] [Related]

  • 25. Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson's Disease.
    Udupa K, Bahl N, Ni Z, Gunraj C, Mazzella F, Moro E, Hodaie M, Lozano AM, Lang AE, Chen R.
    J Neurosci; 2016 Jan 13; 36(2):396-404. PubMed ID: 26758832
    [Abstract] [Full Text] [Related]

  • 26. Beta burst dynamics in Parkinson's disease OFF and ON dopaminergic medication.
    Tinkhauser G, Pogosyan A, Tan H, Herz DM, Kühn AA, Brown P.
    Brain; 2017 Nov 01; 140(11):2968-2981. PubMed ID: 29053865
    [Abstract] [Full Text] [Related]

  • 27. Dopamine and deep brain stimulation accelerate the neural dynamics of volitional action in Parkinson's disease.
    Köhler RM, Binns TS, Merk T, Zhu G, Yin Z, Zhao B, Chikermane M, Vanhoecke J, Busch JL, Habets JGV, Faust K, Schneider GH, Cavallo A, Haufe S, Zhang J, Kühn AA, Haynes JD, Neumann WJ.
    Brain; 2024 Oct 03; 147(10):3358-3369. PubMed ID: 38954651
    [Abstract] [Full Text] [Related]

  • 28. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T, Uchiyama T, Higuchi Y, Asahina M, Hirano S, Yamanaka Y, Kuwabara S.
    PLoS One; 2015 Oct 03; 10(9):e0138462. PubMed ID: 26394059
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
    Timmermann L, Braun M, Groiss S, Wojtecki L, Ostrowski S, Krause H, Pollok B, Südmeyer M, Ploner M, Gross J, Maarouf M, Voges J, Sturm V, Schnitzler A.
    Mov Disord; 2008 Jan 30; 23(2):218-27. PubMed ID: 18044706
    [Abstract] [Full Text] [Related]

  • 30. Cortical correlates of susceptibility to upper limb freezing in Parkinson's disease.
    Scholten M, Govindan RB, Braun C, Bloem BR, Plewnia C, Krüger R, Gharabaghi A, Weiss D.
    Clin Neurophysiol; 2016 Jun 30; 127(6):2386-93. PubMed ID: 27178857
    [Abstract] [Full Text] [Related]

  • 31. The network of causal interactions for beta oscillations in the pedunculopontine nucleus, primary motor cortex, and subthalamic nucleus of walking parkinsonian rats.
    Li M, Zhou M, Wen P, Wang Q, Yang Y, Xiao H, Xie Z, Li X, Wang N, Wang J, Luo F, Chang J, Zhang W.
    Exp Neurol; 2016 Aug 30; 282():27-36. PubMed ID: 27163550
    [Abstract] [Full Text] [Related]

  • 32. Pallidal deep brain stimulation modulates excessive cortical high β phase amplitude coupling in Parkinson disease.
    Malekmohammadi M, AuYong N, Ricks-Oddie J, Bordelon Y, Pouratian N.
    Brain Stimul; 2018 Aug 30; 11(3):607-617. PubMed ID: 29422442
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phase-Dependent Suppression of Beta Oscillations in Parkinson's Disease Patients.
    Holt AB, Kormann E, Gulberti A, Pötter-Nerger M, McNamara CG, Cagnan H, Baaske MK, Little S, Köppen JA, Buhmann C, Westphal M, Gerloff C, Engel AK, Brown P, Hamel W, Moll CKE, Sharott A.
    J Neurosci; 2019 Feb 06; 39(6):1119-1134. PubMed ID: 30552179
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Differential dopaminergic modulation of spontaneous cortico-subthalamic activity in Parkinson's disease.
    Sharma A, Vidaurre D, Vesper J, Schnitzler A, Florin E.
    Elife; 2021 Jun 04; 10():. PubMed ID: 34085932
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Parkinson's disease uncovers an underlying sensitivity of subthalamic nucleus neurons to beta-frequency cortical input in vivo.
    Baaske MK, Kormann E, Holt AB, Gulberti A, McNamara CG, Pötter-Nerger M, Westphal M, Engel AK, Hamel W, Brown P, Moll CKE, Sharott A.
    Neurobiol Dis; 2020 Dec 04; 146():105119. PubMed ID: 32991998
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.